Araştırma Makalesi

Evaluation of UCA1/miR-138/CDK6 Network in the Patients with Laryngeal Squamous Cell Carcinoma

Cilt: 34 Sayı: 5 31 Ekim 2024
PDF İndir
EN TR

Evaluation of UCA1/miR-138/CDK6 Network in the Patients with Laryngeal Squamous Cell Carcinoma

Öz

Objective: Noncoding RNAs (ncRNAs) have the potential to be diagnostic and therapeutic targets, in many cancer types. miRNA ‐ mRNA ceRNA (competing endogenous RNA) network in cancer has been an interesting topic that has been studied in recent years. We aimed to investigate the relationship of UCA1/miR-138/CDK6 network with laryngeal squamous cell carcinoma (LSCC). Material and Methods: We studied with the cancerous tissue and as the control; neighboring normal tissue samples of the patients with diagnosis of LSCC. UCA1, miR-138 and CDK6 expression analysis was made by quantitative real-time PCR (qRT-PCR) method after RNA isolation of the samples. Results: Expressions of cancerous tissue samples and normal adjacent tissue samples as controls were compared. CDK6 and UCA1 levels were increased and miR-138 levels were found to be decreased in cancer tissues but not statistically significant. Conclusions: To the best of our knowledge there is no study to provide an expression profile of the UCA1/CDK6/miR-138 network for LSCC patients. Although we could not obtain statistically significant results, our results were similar with the UCA1, miR‐138, and CDK6 axis literature. Further studies with larger patient samples and LSCC cell lines may confirm the function of this axis, which might be a diagnostic and therapeutic target for LSCC.

Anahtar Kelimeler

Long non-coding RNA, lncRNA, Laryngeal cancer, miRNA, UCA1, miR138, CDK6

Destekleyen Kurum

Ataturk University BAP coordinatory unit

Proje Numarası

TTU- 2021-9277

Etik Beyan

This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of ??? University (B.30.2.???.0.01.00/60). Written informed consent was obtained from all participants.

Kaynakça

  1. Kong X, Qi J, Yan Y, et al. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers. J Cell Biochem. 2019;120(10):17963–74.
  2. Zhang Q, Wang H, Zhao Q, et al. Evaluation of Risk Factors for Laryngeal Squamous Cell Carcinoma: A Single-Center Retrospective Study. Front Oncol. 2021;11(February).
  3. Li H, Wang FL, Li W, et al. Aberrant expressed long non-coding RNAs in laryngeal squamous-cell carcinoma. Am J Otolaryngol - Head Neck Med Surg. 2019;40(5):615–25.
  4. Liu H, Sun Y, Tian H, et al. Characterization of long non-coding RNA and messenger RNA profiles in laryngeal cancer by weighted gene co-expression network analysis. Aging (Albany NY). 2019;11(22):10074–99.
  5. Aslantas M, Kilicaslan O, Eröz R,et al.. The Evaluation of the Genetic Variation Types of the Uridine Diphosphate Glucuronosyl Transferase 1A1 Gene by Next-Generation Sequencing and Their Effects on Bilirubin Levels in Obese Children. Genet Test Mol Biomarkers. 2024;28(7).
  6. Doğan M, Eröz R, Tecellioğlu M, et al.. Clinical and Molecular Findings in a Turkish Family Who Had a (c.869- 1G>A) Splicing Variant in PSEN1 Gene with A Rare Condition: The Variant Alzheimer’s Disease with Spastic Paraparesis. Curr Alzheimer Res. 2022;19(3):223–35.
  7. Arslanoğlu I, Eröz R, Yavuzyılmaz F, et al.. Variations In Monogenic Diabetes And Diabetes Susceptibility Genes In Pediatric Cases: Single Center Experience. Acta Endocrinol. 2023;19(4):512–22.
  8. Acat M, Yıldız Gülhan P, Eröz R, et al.. Evaluation of both expression and serum protein levels of caspase-8 and mitogen-activated protein kinase 1 genes in patients with different severities of COVID-19 infection. Mol Biol Rep [Internet]. 2023;50(4):3241–8. Available from: https://doi.org/10.1007/s11033-023-08244-4
  9. Tuşat M, Eroz R, Bölükbaş F, et al. Evaluation of the protective and therapeutic effects of extra virgin olive oil rich in phenol in experimental model of neonatal necrotizing enterocolitis by clinical disease score, ınflammation, apoptosis, and oxidative stress markers. Pediatr Surg Int [Internet]. 2024;40(1). Available from: https://doi.org/10.1007/s00383-024-05669-1
  10. Karagun E, Eroz R. Argyrophilic nucleolar organizing regions in patients with Xeroderma Pigmentosum Group E. Exp Dermatol. 2021;30(3):416–7.

Kaynak Göster

APA
Cinkara, N., Yüce Kahraman, Ç., Tatar, A., & Tatar, A. (2024). Evaluation of UCA1/miR-138/CDK6 Network in the Patients with Laryngeal Squamous Cell Carcinoma. Genel Tıp Dergisi, 34(5), 666-670. https://doi.org/10.54005/geneltip.1493371
AMA
1.Cinkara N, Yüce Kahraman Ç, Tatar A, Tatar A. Evaluation of UCA1/miR-138/CDK6 Network in the Patients with Laryngeal Squamous Cell Carcinoma. Genel Tıp Derg. 2024;34(5):666-670. doi:10.54005/geneltip.1493371
Chicago
Cinkara, Neslihan, Çiğdem Yüce Kahraman, Arzu Tatar, ve Abdulgani Tatar. 2024. “Evaluation of UCA1/miR-138/CDK6 Network in the Patients with Laryngeal Squamous Cell Carcinoma”. Genel Tıp Dergisi 34 (5): 666-70. https://doi.org/10.54005/geneltip.1493371.
EndNote
Cinkara N, Yüce Kahraman Ç, Tatar A, Tatar A (01 Ekim 2024) Evaluation of UCA1/miR-138/CDK6 Network in the Patients with Laryngeal Squamous Cell Carcinoma. Genel Tıp Dergisi 34 5 666–670.
IEEE
[1]N. Cinkara, Ç. Yüce Kahraman, A. Tatar, ve A. Tatar, “Evaluation of UCA1/miR-138/CDK6 Network in the Patients with Laryngeal Squamous Cell Carcinoma”, Genel Tıp Derg, c. 34, sy 5, ss. 666–670, Eki. 2024, doi: 10.54005/geneltip.1493371.
ISNAD
Cinkara, Neslihan - Yüce Kahraman, Çiğdem - Tatar, Arzu - Tatar, Abdulgani. “Evaluation of UCA1/miR-138/CDK6 Network in the Patients with Laryngeal Squamous Cell Carcinoma”. Genel Tıp Dergisi 34/5 (01 Ekim 2024): 666-670. https://doi.org/10.54005/geneltip.1493371.
JAMA
1.Cinkara N, Yüce Kahraman Ç, Tatar A, Tatar A. Evaluation of UCA1/miR-138/CDK6 Network in the Patients with Laryngeal Squamous Cell Carcinoma. Genel Tıp Derg. 2024;34:666–670.
MLA
Cinkara, Neslihan, vd. “Evaluation of UCA1/miR-138/CDK6 Network in the Patients with Laryngeal Squamous Cell Carcinoma”. Genel Tıp Dergisi, c. 34, sy 5, Ekim 2024, ss. 666-70, doi:10.54005/geneltip.1493371.
Vancouver
1.Neslihan Cinkara, Çiğdem Yüce Kahraman, Arzu Tatar, Abdulgani Tatar. Evaluation of UCA1/miR-138/CDK6 Network in the Patients with Laryngeal Squamous Cell Carcinoma. Genel Tıp Derg. 01 Ekim 2024;34(5):666-70. doi:10.54005/geneltip.1493371